MIRA
MIRA Pharmaceuticals, Inc. - Common Stock (MIRA)
$66
About MIRA Pharmaceuticals, Inc. - Common Stock (MIRA)
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. The company was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.
Details
Daily high
$0.66
Daily low
$0.61
Price at open
$0.64
52 Week High
$1.69
52 Week Low
$0.51
Market cap
27.7M
Dividend yield
-
Volume
505
Avg. volume
150,026
P/E ratio
-.48
MIRA Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$0.66
Daily low
$0.61
Price at open
$0.64
52 Week High
$1.69
52 Week Low
$0.51
Market cap
27.7M
Dividend yield
-
Volume
505
Avg. volume
150,026
P/E ratio
-.48